A Seed Acceleration Program TO BRIDGE THE GAP

 

BETWEEN ACADEMIC RESEARCH GRANTS AND VENTURE CAPITAL SEED ROUNDS

Hands-on support and preseed funding to life science pioneers, to enable the creation of start-ups and to set the foundations towards seed stage of development.

ADDRESSING THE NEEDS OF LIFE SCIENCE PIONEERS AND START-UPS

BIO-INCUBATOR SEED ACCELERATION PROGRAM (12-18 MONTHS)

WHAT WE DO BRING

End-to-end solutions to accelerate value creation and progression of start-ups towards seed funding stage

Biopark

Biopark BUSINESS PLAN

  • Market and competitive intelligence
  • Asset/technology valuation
  • Disease area strategy
  • Define target product profile
  • Licensing and partnership evaluation
Biopark

Biopark DEVELOPMENT PLAN

  • Drug target validation/ Device Concept validation
  • Drug discovery/Device design and proof-of-concept studies
  • Clear development plan and budget, aligned with target product profile
Biopark

Biopark CORPORATE

  • Identify key team members (C-level management)
  • Identify next round investors
  • Establish IP & build knowhow
  • Prepare investor pitch
  • Part-time CFO services
Biopark

Biopark CAPITAL

  • THE BUTTERFLY FUND:€150k convertible loan
  • Regional R&D and IP grants up to €350k
  • Regional entrepreneurship grant up to €75k/year for 3 years
Biopark

Biopark FACILITIES

  • ULB Open BioLab fully-equipped shared labs & offices
  • Specialized lab equipment and cutting-edge technology platforms (incl. preclinical facilities)
  • 10,000m2 business center

PROVEN TRACK RECORD SINCE 2010

Biopark

35

START-UPS CREATED

Biopark

700

JOBS

Biopark

€720M

RAISED BY ALUMNI

Biopark

INDUSTRY EXPERIENCED & ENTREPRENEURIAL PLATFORMS

TEAM

Biopark

PARTNERSHIP WITH INTERNATIONAL

VC FUNDS

Biopark

BROAD BIOTECH BUSINESS

NETWORK

BUTTERFLY FUND SHAREHOLDERS

  • LSRP

    LSRP was founded in 1988 by Professor Désiré Collen and is a non-profit organization focused on biomedical sciences, which led to the creation of Fund+, a €200 million evergreen fund which invests in Series A and B rounds for innovative life science companies

    LSRP
  • SAMBRINVEST

    With 35 years of experience alongside entrepreneurs, more than 270 companies in portfolio and €160M under management, Sambrinvest is a major player in venture capital in the region of Charleroi Métropole, Wallonia, Belgium. More than an investor, Sambrinvest is the catalyst for local ecosystems development, such as Biotech, Digital and Engineering. Thanks to its expertise, it advises entrepreneurs at every development stage of their projects whilst respecting their management autonomy. For more information, please visit the website

    Biopark Sambrinvest
  • THEODORUS

    Theodorus is an early stage VC fund with over €70 million under management. Active since 2003, Theodorus invests mainly in LifeSciences & Tech start-ups. For more information please visit the website. 

    Biopark Theodorus
  • SELECTION COMMITTEE

    Selection Committee members:

    • Marie Bouillez, Partner at Theodorus
    • Lotfi Yelles, Partner at Theodorus
    • Anne Prignon, CEO of Sambrinvest
    • Helena Pozios, Investment Manager at Sambrinvest
    • Chris Buyse, Managing Partner at Fund+
    • Michel Lussier, Independent Selection Committee Member
    Biopark COMITÉ DE SELECTION